BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6577835)

  • 1. Multiple myeloma with renal failure. A case for intensive treatment.
    Harris DC; Ibels LS; Ravich RB; Isbister JP; Wells JV
    Aust N Z J Med; 1983 Apr; 13(2):163-7. PubMed ID: 6577835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure in multiple myeloma.
    Booth LJ; Minielly JA; Smith EK
    Can Med Assoc J; 1974 Aug; 111(4):334-5. PubMed ID: 4850422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of multiple myeloma treated with long-term peritoneal dialysis].
    Uriu K; Kaizu K; Abe R; Oda S; Chiba S; Eto S; Suzuki H
    J UOEH; 1984 Dec; 6(4):391-6. PubMed ID: 6522889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal failure due to multiple myeloma--poor survival on peritoneal dialysis.
    Tapson JS; Mansy H; Wilkinson R
    Int J Artif Organs; 1988 Jan; 11(1):39-42. PubMed ID: 3360511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis in the treatment of renal failure in multiple myeloma.
    Yium J; Martinez-Maldonado M; Eknoyan G; Suki WN
    South Med J; 1971 Nov; 64(11):1403-5. PubMed ID: 5134479
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal replacement therapy in multiple myeloma and systemic amyloidosis.
    Brown JH; Maxwell AP; Bruce I; Murphy BG; Doherty CC
    Ir J Med Sci; 1993 Jun; 162(6):213-7. PubMed ID: 8407257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis in the treatment of multiple myeloma.
    Johnson WJ; Kyle RA; Dahlberg PJ
    Mayo Clin Proc; 1980 Feb; 55(2):65-72. PubMed ID: 7354648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange therapy in rapidly progressive renal failure due to multiple myeloma.
    Pasquali S; Cagnoli L; Rovinetti C; Rigotti A; Zucchelli P
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():27-30. PubMed ID: 4055108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
    Lee CK; Zangari M; Barlogie B; Fassas A; van Rhee F; Thertulien R; Talamo G; Muwalla F; Anaissie E; Hollmig K; Tricot G
    Bone Marrow Transplant; 2004 Apr; 33(8):823-8. PubMed ID: 14767499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hemodialysis in myelomatosis.
    Leech SH; Polesky HF; Shapiro FL
    Ann Intern Med; 1972 Aug; 77(2):239-42. PubMed ID: 4641657
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodialysis: an appropriate therapy in myeloma-induced renal failure.
    Sharland A; Snowdon L; Joshua DE; Gibson J; Tiller DJ
    Am J Kidney Dis; 1997 Dec; 30(6):786-92. PubMed ID: 9398122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma.
    Korzets A; Tam F; Russell G; Feehally J; Walls J
    Am J Kidney Dis; 1990 Sep; 16(3):216-23. PubMed ID: 2399914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal failure in multiple myeloma. Pathogenesis and prognostic implications.
    Alexanian R; Barlogie B; Dixon D
    Arch Intern Med; 1990 Aug; 150(8):1693-5. PubMed ID: 2383164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure.
    Tauro S; Clark FJ; Duncan N; Lipkin G; Richards N; Mahendra P
    Bone Marrow Transplant; 2002 Oct; 30(7):471-3. PubMed ID: 12368962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in multiple myeloma with renal failure.
    Wahlin A; Löfvenberg E; Holm J
    Acta Med Scand; 1987; 221(2):205-9. PubMed ID: 3591456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma.
    Dimopoulos MA; Cheung MC; Roussel M; Liu T; Gamberi B; Kolb B; Derigs HG; Eom H; Belhadj K; Lenain P; Van der Jagt R; Rigaudeau S; Dib M; Hall R; Jardel H; Jaccard A; Tosikyan A; Karlin L; Bensinger W; Schots R; Leupin N; Chen G; Marek J; Ervin-Haynes A; Facon T
    Haematologica; 2016 Mar; 101(3):363-70. PubMed ID: 26659916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients.
    Cavo M; Baccarani M; Galieni P; Gobbi M; Tura S
    Nouv Rev Fr Hematol (1978); 1986; 28(3):147-52. PubMed ID: 3748798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development and treatment of renal insufficiency in multiple myeloma].
    Mølby L; Hansen HH; Jensen EL
    Ugeskr Laeger; 1994 Jul; 156(30):4343-7. PubMed ID: 8066935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.